Literature DB >> 21277747

Distributed lags time series analysis versus linear correlation analysis (Pearson's r) in identifying the relationship between antipseudomonal antibiotic consumption and the susceptibility of Pseudomonas aeruginosa isolates in a single Intensive Care Unit of a tertiary hospital.

Viktorija Erdeljić1, Igor Francetić, Zrinka Bošnjak, Ana Budimir, Smilja Kalenić, Luka Bielen, Ksenija Makar-Aušperger, Robert Likić.   

Abstract

The relationship between antibiotic consumption and selection of resistant strains has been studied mainly by employing conventional statistical methods. A time delay in effect must be anticipated and this has rarely been taken into account in previous studies. Therefore, distributed lags time series analysis and simple linear correlation were compared in their ability to evaluate this relationship. Data on monthly antibiotic consumption for ciprofloxacin, piperacillin/tazobactam, carbapenems and cefepime as well as Pseudomonas aeruginosa susceptibility were retrospectively collected for the period April 2006 to July 2007. Using distributed lags analysis, a significant temporal relationship was identified between ciprofloxacin, meropenem and cefepime consumption and the resistance rates of P. aeruginosa isolates to these antibiotics. This effect was lagged for ciprofloxacin and cefepime [1 month (R=0.827, P=0.039) and 2 months (R=0.962, P=0.001), respectively] and was simultaneous for meropenem (lag 0, R=0.876, P=0.002). Furthermore, a significant concomitant effect of meropenem consumption on the appearance of multidrug-resistant P. aeruginosa strains (resistant to three or more representatives of classes of antibiotics) was identified (lag 0, R=0.992, P<0.001). This effect was not delayed and it was therefore identified both by distributed lags analysis and the Pearson's correlation coefficient. Correlation coefficient analysis was not able to identify relationships between antibiotic consumption and bacterial resistance when the effect was delayed. These results indicate that the use of diverse statistical methods can yield significantly different results, thus leading to the introduction of possibly inappropriate infection control measures.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277747     DOI: 10.1016/j.ijantimicag.2010.11.030

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

2.  Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study.

Authors:  Fumitaka Terahara; Hiroshi Nishiura
Journal:  J Int Med Res       Date:  2019-08-01       Impact factor: 1.671

3.  Effects of bracing on pelvic parameters in adolescent idiopathic scoliosis: A retrospective study.

Authors:  Kepeng Li; Guoju Ma; Heyi Zhao; Ye Han; Jinzeng Zuo; Jun Miao; Jingan Zhang; Xijie Wang
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

4.  Compressive Strength Prediction of PVA Fiber-Reinforced Cementitious Composites Containing Nano-SiO2 Using BP Neural Network.

Authors:  Ting-Yu Liu; Peng Zhang; Juan Wang; Yi-Feng Ling
Journal:  Materials (Basel)       Date:  2020-01-22       Impact factor: 3.623

5.  Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology.

Authors:  Sirui Guo; Jiahong Wang; Yunjia Wang; Ying Zhang; Kaishun Bi; Zhou Zhang; Qing Li
Journal:  Oxid Med Cell Longev       Date:  2019-12-31       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.